Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OHR Pharmaceutical Inc (NASDAQ:OHRP)

0.6261
Delayed Data
As of Jun 23
 -0.0039 / -0.62%
Today’s Change
0.56
Today|||52-Week Range
4.05
-58.26%
Year-to-Date
No recent news for OHR Pharmaceutical Inc.

Today’s Trading

Previous close0.63
Today’s open0.63
Day’s range0.60 - 0.66
Volume333,498
Average volume (3 months)329,632
Market cap$35.4M
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-51.85%
Earnings growth (this year)-15.85%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.81

Competitors

 Today’s
change
Today’s
% change
PPHMPPeregrine Pharmaceut...-0.17-0.77%
NVLSNivalis Therapeutics...+0.03+1.30%
EBIOEleven Biotherapeuti...+0.05+3.40%
CHMAChiasma Inc-0.05-3.33%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$0.00
Annual profit (last year)-$25.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Jason Scott Slakter
CFO &
Principal Accounting Officer
Samuel I. Backenroth
Corporate headquarters
New York, New York

Forecasts